| Analysis | Metabolite Name | Measured Value | Units | Construct |
|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 1047 | Peak area | Noxa knockdown |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 1516 | Peak area | Control lentivirus |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 3317 | Peak area | Control lentivirus |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 3741 | Peak area | Noxa knockdown |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | 4723 | Peak area | Control lentivirus |
| Reversed phase POSITIVE ION MODE | SPHINGOSINE (CAS# 123-78-4); (M+H)+ | Peak area | Noxa knockdown |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|